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Background: Lung cancer is the most common fatal malignacy and also the primary cause of cancer mortality.
Participation in lung screening is an important step in diagnosing patient in early stage and it can promise better
outcomes. The aim of this preliminary study was to determinate the differences in the participation rate of smokers
and non-smokers in lung cancer screening and to determine the communication strategies to increase the
participation rate.
Methods: In the given period of time (from May to August 2012) out of 1426 people who participated in the lung
screening program 1,060 adult volunteers (331 males and 729 females, average age 54.0±9.3 years), completed fully
and anonymously author’s questionnaire that contained 28 questions. 25.7% of the respondents were smokers
(n=272), 64.6% have never smoked, while 9.7% were former smokers.
Results: Mostly former smokers considered lung screening as an effective method for early detection of pulmonary
diseases (86.4%). The most important source (41.0%) of information was the general practitioner. The participation
rate of non-smokers is higher in lung screening than the ratio of non-smokers in the population. The unclear data
suggest that smokers need distinct, concise messages to know why they should regularly undergo lung screening
and doctors have a major role in this.
Conclusions: We found that smokers significantly more frequently took part in lung screening annually. It is
positive that the participation rate of former smokers is higher than non-smokers, it is just a bit lower than the
participation rate of smokers—both in annual and biannual participation. The participation rate of non-smokers is
higher in lung screening than the rate of non-smokers in the population.
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Lung cancer is the leading cancer diagnosis worldwide,
since 1985 [1]. Lung cancer is the most common cause
of cancer mortality worldwide, its leading position
strengthened according to trends [2-5]. Approximately
80-90% of the patients are smoking [6]. 75% of the pa-
tients have incurable, locally advanced or metastatic can-
cer when it is diagnosed. The five year survival rate is
60% for stage I lung cancer, it is 5% for stage IV lung
cancer. Only 15% of the patients survive more than five* Correspondence: lelovics@yahoo.com
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reproduction in any medium, provided the oryears [7]. Lung cancer is the seventh leading cause of
deaths among solid tumors in non-smokers. 15% of lung
cancer patients have never smoked. In non-smokers lung
cancer is more frequent in women and familial cluster-
ing is also more typical and the incidence of adenocar-
cinoma is higher than squamous cell carcinoma [8].
Lung cancer is a public health problem in developed
countries; and it has been shown that the worst situation
is in Hungary in all countries [9].
While professionals have long discussions about “to
screen or not to screen” it is worth to pay attention to this
problem from a completely different aspect. If we decide to
screen, a major challenge for professionals is to reach that
the more people take part in the screening from the risktd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to convince the target groups and as a result to reach a
higher participation rate in the screening programs.
The lung screening program was introduced in
Hungary in 1960 for screening Tuberculosis (TB), using
chest X-ray. Since the occurrence of the disease has de-
creased in the past decades the meaning of the screening
program has also changed. Instead of TB currently one
of the main aims of the program is to detect lung
cancer.
The program provides opportunity for the people aged
over 40 years to take part in the screening annually. All
arising expenses are covered by the Hungarian National
Health Insurance Fund.
Today, in lung cancer screening more and more pro-
fessionals vote for low-dose CT screening [10] according
to methodological aspects, however a number of param-
eters do not have uniform criteria: the age of included
people varies in different countries [11,12] (in Hungary
it is between 40 and 65 years), the interval of screening
also varies: one or two [13] year intervals can be found.
In general, the health economic aspects of expendi-
tures for preventive screening, including lung cancer
screening, are analyzed to show the health gains of the
certain expenditures for the insurance companies. (Au-
thors state that the value of human life cannot be
expressed by money or numbers). At the time of the al-
location of scarce resources, in many cases a decision
must be taken that a curative and preventive care form
receives support, while another do not get funding. It is
very important that preventive screenings will be more
and more efficient from the first step of the process.
From prevention programs any feedback is rarely
made, the effectiveness of these programs contains a
number of random, unpredictable elements.
In Central and Eastern European countries researchers
calculated the cumulative risk of lung cancer in former
smokers. According to their results quitting smoking be-
fore the age 50 can decrease the risk of lung cancer with
67-83%. These results show that quitting smoking has a
very important role in the reduction of lung cancer
caused mortality risk [14] and prevention programs have
a major role in this issue. The results of international
studies indicate that a screening program can also be an
effective tool in successful smoking cessation.
In the United States Zafar et al. analyzed the effective-
ness of lung cancer screening on smokers and former
smokers. In the prospective study low-dose CT was
performed. 22% of the participants had previously can-
cer, 83% had family history of cancer and 52% of these
were lung cancer. 47% of the participants were former
smokers. 11% of the smokers had quit smoking and 45%
decreased smoking after the first screening. It was more
typical in younger participants (<65 years). 64% of theparticipants thought that early detection of lung cancer
improves survival. Healthy lifestyle was common among
participants—including exercising, healthy diet and the
use of dietary supplements. 39% spent more attention
on their diet and the use of dietary supplements in-
creased with 16% after the first screening. According to
these results screening may have a positive effect on
people’s lifestyle [15].
Screening has also shown positive effects in the British
Family Heart Study. The number of smokers decreased
after one year of the screening—19% versus 23%; p<.001
[16]. However, there was no significant difference in the
ratio of smokers before the screening and three years
later in the OXOCHECK Study—25% versus 26%; p=.44
[17,18].
The aim of the study was to determinate the differ-
ences between the participation rate of smokers and
non-smokers in lung cancer screening among volunteers
representing the adult population. What conclusions can
be made for more effective communication strategy?
Can the rate of smoking be determined, which needs an-
other (way, type, etc.) communication strategy to in-
crease the participation rate in the screening.
Methods
In the given period of time (from May to August 2012)
out of 1426 people who participated in the lung screen-
ing program 1,060 adult volunteers (331 males/31.2%/
and 729 females/68.8%/, average age 54.0±9.3 years),
completed fully and anonymously (74.3%) our question-
naire that contained 28 questions (see Figure 1). We
edited the questionnaire on the basis of validated ques-
tionnaires of the WHO. It contained open-ended and
close-ended questions.
Inclusion criteria: (1) voluntary participation in lung
screening, (2) completing the questionnaire voluntary
and fully, (3) asymptomatic participants (no pulmonary
symptoms).
Exclusion criteria: (1) not fully completed question-
naire, (2) pulmonary symptoms.
There is no significant difference in the average age of
the participant males and females (Table 1) and also the
distribution of age (see Figure 2). The survey represents
the adult population of Somogy County (n=170,000)
according to age and place of residence.
Average, standard deviation, minimum, maximum and
based on these the ranges of variation were calculated for
the each groups. 95% confidence intervals were calculated,
we applied two-sample t-tests and univariate and multiple
linear regression analysis. Parameters were analyzed not
only for the whole population but also in age sub-groups.
Data were analyzed by using SPSS v20.0.0.
Ethical approval was issued by “Kaposvári Egyetem
Egészségügyi Centrum Etikai Bizottsága [In Hung.] =
Figure 1 Participants of the survey.
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ter” for this study corresponding to the current national
and international ethical laws and guidelines. The refer-
ence numbers are: EC 611/2012. Copies of the written
documentations are available for review by the Editor-in-
Chief of this journal.
Results
Lung screening-related attitudes
We analyzed the average screening visits with line up
the participants according to age and divided them into
ten equal groups. We found that in younger age groups
participation in screening is more frequent (Table 2).
People less and less believe in it with aging (see
Figure 3).
We examined the participants according the level of
education and we found that people with the lowest
education level participate in screenings the least: only
37.5% participate in screening annually, while from
higher educational level groups 60.8% participate
annually.Table 1 Characterization of participant according to age
Age Males Females All
(n=331) (n=729) (n=1,060)
Mean 54.5 years 53.8 years 54.0 years
Standard deviation 9.8 years 9.1 years 9.3 years
Min. 29.0 years 18.0 years 18.0 years
Max. 83.0 years 95.0 years 95.0 years
Median 54.0 years 54.0 years 54.0 yearsThe questionnaire contained questions about the opin-
ion of the respondent about the effectiveness of the
screening. Interestingly the respondents who did not
exactly know the purpose of the screening programs and
they answered with “I do not know” (58.0%) participate
in screening rarely, not those who think that it is not
effective.
The ratio of smokers, smoking rate
25.7% of the respondents identified themselves as
smokers (n=272), 47.4% of them started to smoke before
the age of 18. All of the smokers smoked a week before
the survey. The highest ratios of smokers were in the
age groups of 39 year olds or younger and in the group
of 45-49 year olds (see Figure 4). The highest proportion
of smokers was in the group of 45-49 year olds (see
Figure 5).
66.2% of the smokers smoked at least a half pack of
cigarette per day, 19.1% smoked at least one pack of
cigarette (19 cigarettes) per day. Most people (46.9%)
smoked half–one pack of cigarette per day. The average
pack-year of cigarette smoking was 28.5±17.8 (it varied
between 2.0 and 112.0 pack years) for smokers; it was
34.0±21.6 (it varied between 2.0 and 87.0 pack years) for
former smokers.
64.6% of the respondents have never smoked, while
9.7% were former smokers.
Smokers versus non-smokers
Close relationship was not found between participation
in screening and smoking. Although non-smokers
Figure 2 Distribution of participants according to age (n=1,060).
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is statistically not significant. However if we analyzed
only smokers we found interesting results. Those who
smoked less (maximum 10 cigarettes/day) participate
more frequently in screenings (72.8%) than heavy
smokers (54.4%).
For the question “What do you think, which disease
detection is the most important in lung screening?”
former smokers answered TB (tuberculosis) in signifi-
cantly (p < .05) higher rate, while smokers answered
lung cancer in also significantly (p<.05) higher rate (seeTable 2 Annual average participation in lung screening
according to deciles
Decile Average age Average participation in screening
1 39.13 71.4%
2 43.77 70.0%
3 49.33 58.6%
4 52.16 60.4%
5 54.68 58.6%
6 56.61 52.0%
7 58.55 54.0%
8 61.36 43.0%
9 65.18 44.0%
10 74.47 41.9%Figure 6). The ratio of respondents with the answer “I
do not know what disease detection is the most import-
ant in lung screening” was the highest among non-
smokers. 73.8% of non-smokers thought that the most
important is the detection of TB, 52.6% of smokers
thought the same about lung cancer, 48.8% of non-
smokers thought the same. 42.7% of former smokers
considered the detection of lung cancer as the most im-
portant in lung screening.
Mostly former smokers considered lung screening as
an effective method for early detection of pulmonary
diseases (86.4%). High proportion of both smokers and
non-smokers (7.4% and 8.5%) could not give a substan-
tial answer for this question (see Figure 7).
The highest proportion who thinks that “with regular
lung screening serious pulmonary diseases can be
avoided” is from non-smokers (see Figure 8).
Information sources
Those participants who obtain information from more
sources significantly more frequently (p < .05) go to
screening: maximum from one source 53.9%, two-three
sources 59.6%, four or more sources 71.6%.
In general, the most important sources (41.0%) of in-
formation are the professionals of the general practi-
tioner’s office (and also the information materials that
may find there). Habit also plays an important role in
Figure 3 Age and participation in screening.
Figure 4 Ratio of smokers in the different age groups (n=1,060).
Moizs et al. BMC Public Health 2013, 13:914 Page 5 of 10
http://www.biomedcentral.com/1471-2458/13/914
Figure 5 Distribution of smokers according to age (n=272).
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screening. Every fifth person (19.9%) uses TV or radio as
a source of information. The other screenings played a
more important role (5.4%) in the participation of lung
screening than internet (3.5%) or school (0.4%).
There are major differences between the information
sources of the three sub-samples (smokers, former
smokers, non-smokers), so significantly higher propor-
tion of non-smokers were informed by the general prac-
titioner about the participation in lung screening, whileFigure 6 Answers for the question “What do you think, which diseasemost of the smokers and former smokers participated
due to habit (See Figure 9).
Smokers mostly considered the general practitioner or
the physician (4.7-4.7) and the health professional (4.5)
to be accurate. Former smokers and non-smokers an-
swered the same, but in a 1 to 5 rating scale the
achieved scores were lower than the scores that smokers
gave (see Figure 10). In the accuracy of pharmacists
there were no significant differences in the three sub-
samples, and also in the accuracy of the other sources.detection is the most important in lung screening?”.
Figure 7 Perceived effectiveness of lung screening in early detection of pulmonary diseases.
Figure 8 The distribution of answers for the question ”With regular lung screening serious pulmonary diseases can be avoided”.
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Figure 9 “Where/Who told you that you should go to lung screening?” incidence of the answers of the sub-samples.
Figure 10 Accuracy of different sources. Legend: 1: least authentic, 5: most authentic.
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Non-smokers took part in lung screening annually in sig-
nificantly (p<.05) lower proportion (54.9%), 60.7% of the
smokers, 54.9% of non-smokers went annually to the
screening, further 17.5%-22.9% went biannually. There is
no significant difference between the tendencies of the
participation frequency of the two groups. (see Figure 11).
There is a strong correlation (r=.38; p=.01) between
the frequency of participation in lung screening and the
number of cigarettes smoked per day. Also the participa-
tion in other screenings (breast, prostate, osteoporosis,
etc.) shows significant correlation (r=.27; p<.05).
With the increase of age the participation rate of non-
smokers in lung screening significantly increases per decades.
While in the 41-50 and 51-60 years age groups the participa-
tion of smokers (less than half pack/day) was typical, in older
age groups only smokers who smoke at least half pack per
day took part in the screening. 92.1% of smokers and 100%
of former smokers read/heard about smoking caused lung
cancer. (The ratio in non-smokers was 94.6%).
Discussion
The participation rate of non-smokers is higher in lung
screening than the rate of non-smokers in the popula-
tion. Similar results were found in the National Lung
Screening Trial: according to sex and pack-year history
participants represented the population of the United
States, but their average age was younger than theFigure 11 Frequency of participation in lung screening of smokers anpopulation, they were better educated and the ratio of
smokers was lower [17]. However, every tenth smoker in
the United States is diagnosed with lung cancer [18].
Significantly (p<.05) lower ratio of smokers, particu-
larly men, from the 50-54 years and older age groups
participated voluntary in lung screening. In these age
groups the currently available information channels and
forms of communication are not sufficient.
The knowledge of former smokers about smoking and
its harms is wide enough. After they stop smoking their
health behavior and health consciousness becomes
higher than smokers and non-smokers. We can con-
clude this from the further results, such as participation
in other screenings, BMI calculated from measured pa-
rameters, data about nutrition and exercise.
Surprisingly, former smokers referred to school studies in
the highest proportion whereas previously they smoked
(60% of them became regular smoker before the age of 18).
Smokers significantly more frequently took part in
lung screening annually. It is positive—in contrast to the
data from the literature [19]—that the participation rate
of former smokers is higher than non-smokers, it is just
a bit lower than the participation rate of smokers—both
in annual and biannual participation. So the “protection”
that they might assume to develop after they stop smok-
ing could not be proved according to the results.
There is a strong correlation (r=.33; p=.01) between
the number of cigarettes smoked per day and the firstd non-smokers.
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the time of your first lung screening?”). This fact and
also the similar result about the number of cigarettes
smoked per day and the frequency of participation in
lung screening shows that a part of smokers takes ser-
iously lung screening, in addition heavy smokers took
part more frequently in the screening.
At the same time we have no data about smokers who
do not participate, why do they not participate. Further-
more, there is negative correlation between the time (age)
of the first cigarette and the annual participation in
screening. It is important that our study showed that
higher proportion of smokers know that participation is
not free for everyone. And higher proportion thought that
lung screening is a radiation exposure risk. They also be-
lieve that the chest radiography is not an outdated or less
effective method in lung screening. The unclear data sug-
gest that smokers need clear, concise messages to know
why they should regularly undergo lung screening.Conclusions
The aim of this preliminary study was to determinate the
differences in the participation rate of smokers and non-
smokers in lung cancer screening and to determine the
communication strategies to increase the participation rate.
We found that smokers significantly more frequently
took part in lung screening annually. It is positive that the
participation rate of former smokers is higher than non-
smokers, it is just a bit lower than the participation rate of
smokers—both in annual and biannual participation. The
participation rate of non-smokers is higher in lung screen-
ing than the rate of non-smokers in the population.
In order to summarize and evaluate the experiences
we can state that besides the high-tech achievements,
doctors have a major role in the communication with
the targeted groups.
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